We are live on ! Find out more
VYNT

Vyant Bio, Inc. Common Stock
VYNT

Delisted

VYNT was delisted on the 12th of May, 2023.

Back to rankings

23 hedge funds and large institutions have $485K invested in Vyant Bio, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 23 → 23 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

56% less capital invested

Capital invested by funds: $1.1M → $485K (-$619K)

Holders
23
Holders Change
–
Holders Change %
0%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$132K
2
UBS Group
UBS Group
Switzerland
+$4.81K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$1.42K
4
Victory Capital Management
Victory Capital Management
Texas
+$1.11K
5
BlackRock
BlackRock
New York
+$58

Top Sellers

Rank Fund Capital Flow
1
PCM
Perkins Capital Management
Minnesota
-$383K
2
VF
Virtu Financial
New York
-$24K
3
LTFS
Ladenburg Thalmann Financial Services
Florida
-$5.24K
4
TSS
Two Sigma Securities
New York
-$662
5
Morgan Stanley
Morgan Stanley
New York
-$19
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$391K +$132K +6,788 +37%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$22K – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$20K – – –
UBS Group
4
UBS Group
Switzerland
$13K +$4.81K +247 +44%
DM
5
Diker Management
New York
$7K – – –
PCM
6
Perkins Capital Management
Minnesota
$4K -$383K -19,659 -99%
TSS
7
Two Sigma Securities
New York
$4K -$662 -34 -12%
Acadian Asset Management
8
Acadian Asset Management
Massachusetts
$4K – – –
FPB
9
First PREMIER Bank
South Dakota
$4K – – –
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
$4K +$1.42K +73 +46%
LTFS
11
Ladenburg Thalmann Financial Services
Florida
$3K -$5.24K -269 -58%
Northern Trust
12
Northern Trust
Illinois
$3K – – –
BG
13
Bahl & Gaynor
Ohio
$2K – – –
CPA
14
Court Place Advisors
Maryland
$1K – – –
SWM
15
SeaCrest Wealth Management
New York
$1K – – –
BlackRock
16
BlackRock
New York
$1K +$58 +3 +6%
Victory Capital Management
17
Victory Capital Management
Texas
$1K +$1.11K +57 New
VF
18
Virtu Financial
New York
– -$24K -966 Closed
Morgan Stanley
19
Morgan Stanley
New York
– -$19 -1 -25%

VYNT Hedge Fund Activity: Q3 2019 in Review

23 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Vyant Bio, Inc. Common Stock (VYNT) for Q3 2019, worth a combined $485K — down 56% from $1.1M a quarter earlier.

Fund positioning in VYNT was balanced in Q3 2019: 1 fund opened new positions, 1 closed out, 4 added to existing stakes and 4 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $132K. The largest seller was Perkins Capital Management, cutting an estimated $383K.

  • 23 institutional investors held Vyant Bio, Inc. Common Stock (VYNT) as of Q3 2019, unchanged from Q2 2019.
  • Funds reported $485K of Vyant Bio, Inc. Common Stock stock for Q3 2019, down 56% quarter-over-quarter.
  • 1 fund opened new Vyant Bio, Inc. Common Stock positions in Q3 2019 and 1 closed out, a net change of 0 holders.
  • The largest Vyant Bio, Inc. Common Stock buyer in Q3 2019 was Renaissance Technologies, an estimated $132K added.
  • The largest Vyant Bio, Inc. Common Stock seller in Q3 2019 was Perkins Capital Management, an estimated $383K sold.

Based on aggregated 13F filings for Q3 2019.